DBV eyes European expansion with Bioprojet deal
This article was originally published in Clinica
Executive Summary
Epicutaneous diagnostics specialist DBV Technologies has signed a distribution deal for its Diallertest cow’s milk allergy test with Bioprojet pharma, a drug company specialising in paediatrics. The deal will see Bioprojet promote and distribute the test in France and perhaps beyond: Bioprojet CEO Jeanne-Marie Lecomte said that the firm was “looking forward to working with DBV to make Diallertest Milk more widely available throughout Europe”. Financial terms of the agreement were not revealed. Paris, France-based DBV said that it is currently working on further developing the Diallertest line to include diagnosis tools for wheat, soya and dustmite allergies in children.